WHO and Gilead Sciences extend collaborative agreement to enhance access to treatment for visceral leishmaniasis

Authors

Article Type

News

First Page

227

Last Page

228

Recommended Citation

(2023) "WHO and Gilead Sciences extend collaborative agreement to enhance access to treatment for visceral leishmaniasis," Saudi Medical Journal: Vol. 44: Iss. 2, Article 18.
DOI: https://doi.org/10.15537/1658-3175.8130